The cancer studies are also of interest because they show that WNT5A stimulates MMP2 expression through ROR2 (55, 56), a receptor that was expressed at low levels in the RA FLS and that was not involved in the WNT5A modulation of migration suggesting a possible mechanism of the differential MMP2 regulation. Here, ROR2 is linked to rheumatoid arthritis.